"Das Kantonsspital Olten ist für die medizinische Versorgung der rund 100'000 Einwohner in der Region Olten-Gösgen und Thal-Gäu zuständig. Daneben bieten wir in Olten folgende Schwerpunkte an: die Akutgeriatrie soH, bariatrische Chirurgie (Adipositaschirurgie), das Brustzentrum Mittelland, die Wirbelsäulenchirurgie soH und das Urologische Kompetenzzentrum soH."

During the past decade, Kantonsspital Olten conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 1 clinical trials were completed, i.e. on average, 6.7% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kantonsspital Olten" #1 sponsor was "Swiss Group for Clinical Cancer Research" with 30 trials, followed by "German CLL Study Group" with 2 trials sponsored, "Kantonsspital Olten" with 2 trials sponsored, "AGO Research GmbH" with 1 trials sponsored and "ETOP IBCSG Partners Foundation" with 1 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kantonsspital Olten" #1 collaborator was "Cancer Trials Ireland" with 2 trials as a collaborator, "Cantonal Hospital of St. Gallen" with 2 trials as a collaborator, "Hoffmann-La Roche" with 2 trials as a collaborator, "Janssen-Cilag Ltd." with 2 trials as a collaborator and "Nordic CLL Study Group (NCLLSG)" with 2 trials as a collaborator. Other collaborators include 26 different institutions and companies that were collaborators in the rest 36 trials.

According to Clinical.Site data, the most researched conditions in "Kantonsspital Olten" are "Breast Cancer" (7 trials), "Lung Cancer" (4 trials), "Lymphoma" (4 trials), "Colorectal Cancer" (3 trials) and "Metastatic Breast Cancer" (2 trials). Many other conditions were trialed in "Kantonsspital Olten" in a lesser frequency.

Most popular intervention types in "Kantonsspital Olten" are "Drug" (27 trials), "Biological" (11 trials), "Procedure" (7 trials), "Other" (6 trials) and "Radiation" (6 trials). Other intervention types were less common.

The name of intervention was led by "Ibrutinib" (3 trials), "Rituximab" (3 trials), "Chemotherapy" (2 trials), "Obinutuzumab" (2 trials) and "Radiotherapy" (2 trials). Other intervention names were less common.

The vast majority of trials in "Kantonsspital Olten" are 30 trials for "All" genders, 9 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Kantonsspital Olten". undefined are not yet recruiting, 4 are recruiting, 12 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 19 completed trials in Kantonsspital Olten, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Kantonsspital Olten, 2 "Phase 1" clinical trials were conducted, 17 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 6 trials that are defined as “Not Applicable".